The British company hVIVO, specializing in clinical research, has found 20 thousand volunteers who want to become infected with viruses similar to the coronavirus COVID-19. The purpose of the study is to create a vaccine.
More than 20 thousand volunteers will participate in a vaccine development program for a new type of coronavirus. They were attracted to research by scientists from the British research group hVIVO, writes The Wall Street Journal on March 19.
The volunteers will be given a vaccine, after which they will be artificially infected. But not COVID-19, from which there is no treatment yet, but viruses from the same family. If volunteers do not get sick after administering the drug, then the medicine will be considered effective.
Until the result is received, all participants in the study will be isolated.
Each volunteer will be paid $ 4.5 thousand.
The publication writes that usually several people a day register for participation in such events, however, after the launch of this campaign, more than 20 thousand people signed up for several days.
An outbreak of COVID-19 coronavirus infection began in December 2019 in China. March 11 World Health Organization announced the spread of coronavirus pandemic.
According to Johns Hopkins University, which tracks the spread of coronavirus, as of the morning of March 21 275,434 infections reported worldwide coronavirus infection. Cases with a fatal outcome – 11 399, were cured of COVID-19 88 256 people.